Roxanna Gapstur, Ph.D., R.N., has announced her retirement as president and CEO of WellSpan Health, a position she has held since January 2019. Under her leadership, WellSpan has experienced significant growth, transforming from a $2.5 billion to a $4.7 billion health system, expanding from eight to 12 hospitals, and increasing its patient base from approximately 630,000 to over one million. Gapstur will remain in her role until a successor is appointed, ensuring a smooth transition for the organization and its 23,000 employees across Pennsylvania and Northern Maryland.

Gapstur’s tenure has been marked by a commitment to clinical innovation and a human-centered approach to healthcare. WellSpan has emerged as a national leader in clinical artificial intelligence, facilitating over three million patient interactions to enhance care delivery. Additionally, the organization has prioritized genomic medicine, integrating genetic insights into clinical practice for improved patient outcomes. WellSpan’s achievements include earning the Magnet® designation and national awards for patient safety and quality, reflecting its dedication to exceptional care standards. The partnership with Temple University’s Lewis Katz School of Medicine further exemplifies WellSpan’s commitment to healthcare education and training.

The implications of Gapstur’s leadership extend beyond operational success; her departure signals a pivotal moment for WellSpan as it seeks a successor who can uphold and advance its strategic vision. The focus on identifying a leader who can navigate the complexities of modern healthcare will be crucial for maintaining WellSpan’s momentum in clinical innovation and patient care. As the organization prepares for this transition, it will be essential to ensure that the values and mission established under Gapstur’s guidance continue to thrive, particularly in the evolving landscape of healthspan and longevity research.

Source: globenewswire.com